SOAK: Policy Directions Unpredictable, Self-Developed E-liquids to Launch in March 2024

2Firsts EventsBusiness by 2FIRSTS
Dec.17.2023
SOAK: Policy Directions Unpredictable, Self-Developed E-liquids to Launch in March 2024
At the VAPE CLUB SHOW 2023 in Russia, Dmitry, representative of e-cigarette brand SOAK, discussed the future prospects of the Russian market.

On December 16th, Dmitry, representative of e-cigarette brand SOAK, engaged in a conversation with 2FIRSTS at the VAPE CLUB SHOW 2023 in Russia. During the discussion, Dmitry provided an in-depth analysis of the development prospects of the Russian market and the brand's future new plans.

SOAK: Policy Directions Unpredictable, Self-Developed E-liquids to Launch in March 2024
Product: Saok Image source: 2FIRSTS

 

The recently released e-cigarette regulatory policy by the Russian government has attracted widespread attention from the industry. Dmitry admitted that predicting the direction of the policy is exceptionally challenging.

 

He expressed that starting from March next year, Russia's ban on e-cigarette additives will be implemented, and the pace of strengthened regulation is astonishing. Unlike other countries, Russia has not reduced taxes but instead increased them by tenfold, posing significant challenges to the industry. However, he mentioned the example of Turkey where the sale of e-cigarettes is prohibited, yet e-cigarette stores are thriving, indicating that even under regulatory pressure, there is still enormous market potential for e-cigarettes.

 

Despite facing regulatory uncertainties, Dmitry remains optimistic about the prospects of the Russian market. He believes that the e-cigarette market in Russia is still expanding, with new products constantly emerging, indicating that the entire industry is still in its growth and upward phase.

 

Dmitry revealed that SOAK brand is considering launching a new product line in 2024 or 2025, which may include screen design. He emphasized that the brand remains committed to standing out from the crowd, focusing on unique design and independent research and development.

 

Dmitry mentioned that SOAK is set to launch a new product line in March next year, featuring their own in-house developed e-liquid blended with various natural flavors, promising a unique vaping experience.

 

In this innovative process, the support of a Chinese team has been obtained. SOAK will customize unique flavors based on the needs of users in the Russian region in order to meet the variations in consumer tastes in different areas.

 

Dmitry gives high praise to Chinese e-cigarette brands, stating that 99% of e-cigarettes are manufactured in Shenzhen, China. He believes that Chinese brands hold significant competitiveness in the market. He acknowledges customers' right to choose brands and expresses an open attitude towards Chinese brands as long as they do not affect SOAK's customers.

 

Dmitry shared the brand's marketing strategy, which involves developing through agency channels in Europe, the United States, and the Middle East. Additionally, increased investment will be allocated based on the performance in different regional markets. Logistics plays a crucial role in the expansion of the market, and SOAK plans to allocate substantial funds towards equipment and logistics to ensure the rapid and smooth delivery of products to the target markets.

 

We will allocate one million dollars for equipment and one and a half million dollars for logistics. This can still guarantee profitability. In Turkey, the cost of equipment logistics amounts to 23 dollars," Dmitry said.

 

In conclusion, Dmitry points out that an increasing number of people are recognizing the assistance e-cigarettes provide in quitting smoking. His personal experience also confirms this, as he quit smoking after 20 years and turned to using e-cigarettes. This further underscores the potential value of e-cigarettes in aiding smoking cessation.

 

At this exhibition, SOAK is looking forward to achieving even greater success in future market competition.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia Tobacco Retail Permit Takes Effect October 1, Covering Vapes as More Than 3,000 Businesses Apply in September
Virginia's new retail tobacco permit system took effect October 1, requiring sellers of vapes, nicotine products and related devices and accessories to obtain a Retail Tobacco Permit for each business location. Virginia ABC said more than 3,000 businesses applied in September alone, creating a processing backlog. Qualifying applicants that filed before October 1 may temporarily operate under a Letter of Authorization. The new store-level permit also sits alongside Virginia's existing vape product directory, where sales of unlisted liquid nicotine or nicotine vapor products can trigger civil penalties starting at $5,000.
Regulations
Oct.03
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24